"Factor IXa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Activated form of factor IX. This activation can take place via the intrinsic pathway of blood coagulation by the action of factor XIa and calcium, or via the extrinsic pathway by the action of factor VIIa, thromboplastin, and calcium. Factor IXa serves to activate factor X to Xa by cleaving the arginyl-leucine peptide bond in factor X.
Descriptor ID |
D015949
|
MeSH Number(s) |
D08.811.277.656.300.760.310 D08.811.277.656.959.350.310 D12.776.124.125.375.310 D23.119.375.310
|
Concept/Terms |
Factor IXa- Factor IXa
- Coagulation Factor IXa
- Factor IXa, Coagulation
- Blood Coagulation Factor IX, Activated
- Factor IX, Activated
- Activated Factor IX
- Factor 9A
- Factor Nine A
|
Below are MeSH descriptors whose meaning is more general than "Factor IXa".
Below are MeSH descriptors whose meaning is more specific than "Factor IXa".
This graph shows the total number of publications written about "Factor IXa" by people in this website by year, and whether "Factor IXa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Factor IXa" by people in Profiles.
-
Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis. J Thromb Haemost. 2020 09; 18(9):2202-2204.
-
Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXa. Thromb Res. 2018 10; 170:133-141.
-
Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2019 Sep; 8(6):520-526.